Alcon Inc. - ALC Projected Future Earnings

Corporate company logo of Alcon Vision (ALC)

The visualized price action of Alcon Inc. (ALC) underscores the balanced revenue stream derived from the sale of complex medical technology and the recurring sale of consumables. The current figure stands at 1.88. Alcon Inc. (ALC) dominates the ophthalmology sector through unique cataract treatment solutions and lenses, benefiting from the global aging population. The capital-intensive production of equipment ensures a steady profit flow via the continuous sale of ancillary materials.

ALC - Alcon Corp Expected Net Profit over the range 07/04/2022 - 11/13/2026

ALC (Alcon Inc): analytical breakdowns and indicator data

- stock quotes and analyst forecast:
Stock Quotes Alcon Inc.|ALC - Fair Value Consensus
- issuer market value details:
Market Capitalization Alcon|ALC - Total Enterprise Value
- book capitalization indicators:
Accounting Value per Share Alcon|ALC - Total Stockholders' Equity|Market Capitalization to Book Value Ratio alcon.com|ALC - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Alcon Inc.|ALC - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Alcon Vision|ALC - Company Aggregate Debts|Debt to Book Capitalization Ratio Alcon|ALC - Company Long-Term Debt|Company Short-Term Debts Alcon|Quick Liquidity alcon.com
- earnings and market ratios statistics:
ALC - Company Net Income|Expected Profit Alcon Inc.|ALC - Price to Earnings Multiple|Projected Price to Earnings Alcon|ALC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Alcon|ALC - Operating income before deduction of amortization|Earnings per share for the last twelve months Alcon|ALC - Earnings per share for the last 12 months|Quarterly EPS earnings growth alcon.com|ALC - Net earnings per share growth this year|Expected earnings per share growth for next year Alcon Inc.
Basic company analysis:ALC, Alcon Inc.
Core merchandise of Alcon Inc

The implementation of ESG standards and resource optimization in Alcon Inc. (ALC) ophthalmology product manufacturing directly impact operational efficiency and future margins. The dynamics of expected earnings, reflected through the planned profit trend, make it possible to identify artificial price manipulations and abnormal forecast stability, warning investors of the risks of sudden drawdowns during prolonged sideways price action.

Key competitors

Future Profit BLCO|GKOS: Expected Net Income|Projected Future Earnings APLS|BLTE - Expected Net Profit|Ocular Therapeutix Corp - Future Profit|Harrow Corp (HROW) - Expected Net Profit|Viridian Therapeutics - Projected Future Earnings|Expected Net Profit lenz-tx.com|Oculis AG (OCS) - Expected Profit|EYPT - Company Profit Forecast|KOD (Kodiak Pharma) - Projected Future Earnings|Projected Future Earnings Aldeyra|Expected Profit KALA BIO, Inc. (KALA)|Expected Profit IRD (opusgtx.com)|Projected Future Earnings OKYO (OKYO Pharma)|ADVM - Future Profit|OTLK - Expected Profit|Expected Net Profit Clearside Corp|novabay.com (NBY) - Expected Profit|Net Profit Forecast KPRX|Future Profit ALIM|EYEN: Expected Net Income|Projected Future Earnings GHSI|Company Profit Forecast Ocuphire Corporation|Expected Profit Opthea Limited OPT